Auronext Pharma Profile
Key Indicators
- Authorised Capital ₹ 255.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 124.98 Cr
as on 16-06-2024
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 36.50 Cr
as on 16-06-2024
- Revenue 22.85%
(FY 2023)
- Profit 49.22%
(FY 2023)
- Ebitda 29.61%
(FY 2023)
- Net Worth -1.47%
(FY 2023)
- Total Assets -0.04%
(FY 2023)
About Auronext Pharma
- CIN/LLPIN
U74999TG2009PTC109591
- Company No.
109591
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2009
- Date of AGM
19 Jun 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Auronext Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Racharla  | Company Secretary | 15-Apr-2019 | Current |
| Ravi Yellapragada | CFO | 01-Jul-2021 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sarath Penaka | Director | 20-Aug-2009 | Current |
| Madan Mettu | Director | 31-Aug-2020 | Current |
| Sapna | Director | 23-May-2019 | Current |
| Jacob Joseph | Whole-Time Director | 01-Jul-2021 | Current |
Financial Performance of Auronext Pharma.
Auronext Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.85% increase. The company also saw a substantial improvement in profitability, with a 49.22% increase in profit. The company's net worth dipped by a decrease of 1.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Auronext Pharma?
In 2023, Auronext Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 21 Jul 2016 | ₹35.00 Cr | Satisfied |
Axis Bank Limited Creation Date: 02 Feb 2010 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Auronext Pharma?
Auronext Pharma has a workforce of 293 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Auronext Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auronext Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
